Kölbel Tilo, Gottsäter Anders, Kühme Tobias, Lindh Mats, Ivancev Krasnodar
Vascular Center, Malmö University Hospital, Malmö, Sweden.
Ann Vasc Dis. 2008;1(2):91-101. doi: 10.3400/avd.AVDrev07022. Epub 2008 Oct 24.
Endovascular treatment of acute and chronic iliac vein occlusions has proven to be safe and effective. Recanalization of chronic occlusions with balloon angioplasty and stenting can re-establish normal venous flow in the iliac veins and the IVC and relieve symptoms in the majority of treated patients. CDT with recanalization and stenting of underlying chronically obstructed iliofemoral segments is becoming the treatment of choice for patients with acute iliofemoral thrombosis, as anticoagulation and compression therapy alone are not satisfactory in preventing PTS. The new treatment modalities offer stimulating options for a patient group that is not adequately treated, neither by medical nor open surgical therapy. The substantial effort and additional costs of endovascular treatment appear to be justified by the encouraging mid-term results both for patients with acute and chronic occlusive iliofemoral disease. However, multi-center randomized prospective studies are required to further validate the role of these techniques.
急性和慢性髂静脉闭塞的血管内治疗已被证明是安全有效的。通过球囊血管成形术和支架置入术使慢性闭塞再通,可重新建立髂静脉和下腔静脉的正常血流,并使大多数接受治疗的患者症状得到缓解。对潜在慢性阻塞的髂股段进行再通和支架置入的导管直接溶栓术正成为急性髂股静脉血栓形成患者的首选治疗方法,因为单纯抗凝和压迫治疗在预防血栓后综合征方面并不令人满意。这些新的治疗方式为既未得到药物治疗也未得到开放手术治疗的患者群体提供了令人鼓舞的选择。血管内治疗所需的大量努力和额外费用,似乎因急性和慢性闭塞性髂股疾病患者令人鼓舞的中期结果而合理。然而,需要多中心随机前瞻性研究来进一步验证这些技术的作用。